Shuang Jia Selected Research

Dysbiosis

1/2022	Probiotic normalization of systemic inflammation in siblings of type 1 diabetes patients: an open-label pilot study.
1/2022	Lactiplantibacillus plantarum 299v supplementation modulates β-cell ER stress and antioxidative defense pathways and prevents type 1 diabetes in gluten-free BioBreeding rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shuang Jia Research Topics

Disease

10	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 05/2024 - 12/2004
8	Inflammation (Inflammations) 01/2022 - 04/2015
6	Neoplasms (Cancer) 10/2023 - 01/2007
3	Wounds and Injuries (Trauma) 02/2024 - 10/2023
3	Infections 01/2020 - 04/2015
3	Endotoxemia 11/2015 - 09/2010
2	Dysbiosis 01/2022 - 01/2022
2	Colitis 04/2016 - 12/2012
2	Sepsis (Septicemia) 11/2015 - 09/2010
1	Autoimmune Diseases (Autoimmune Disease) 05/2024
1	Burns 02/2024
1	Bronchopulmonary Dysplasia 01/2022
1	Insulinoma 01/2022
1	Hyperoxia 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Hemorrhage 12/2020
1	Pseudomonas Infections 01/2019
1	Adenocarcinoma 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Lung Neoplasms (Lung Cancer) 06/2018
1	Disease Progression 01/2018
1	Hemophilia A (Haemophilia) 12/2016
1	Activated Protein C Resistance (APC Resistance) 11/2015
1	Arthrogryposis renal dysfunction cholestasis syndrome 06/2015
1	Glucose Intolerance 09/2014
1	Weight Loss (Weight Reduction) 12/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2012
1	Body Weight (Weight, Body) 12/2012
1	Leukemia 06/2011
1	Virus Diseases (Viral Diseases) 09/2007
1	Human Influenza (Influenza) 09/2007

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 02/2024 - 06/2011
3	Insulin (Novolin)FDA Link 05/2024 - 12/2004
3	Proteins (Proteins, Gene)FDA Link 02/2024 - 10/2023
3	HydrogelsIBA 02/2024 - 10/2023
3	Biomarkers (Surrogate Marker)IBA 01/2019 - 10/2010
2	Keratin-14 (Keratin 14)IBA 12/2023 - 10/2023
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 12/2012
2	C-PeptideIBA 11/2018 - 04/2016
2	Phosphotransferases (Kinase)IBA 10/2017 - 06/2017
2	AnticoagulantsIBA 11/2015 - 09/2010
2	Protein CIBA 11/2015 - 09/2010
2	Endothelial Protein C ReceptorIBA 04/2015 - 09/2010
1	Streptozocin (Streptozotocin)FDA Link 02/2024
1	Oxidants (Oxidizing Agents)IBA 12/2023
1	ZincIBA 10/2023
1	CollagenIBA 10/2023
1	Lamin Type B (Lamin B)IBA 10/2023
1	Coloring Agents (Dyes)IBA 10/2023
1	Glutens (Glutelin)IBA 01/2022
1	ursodoxicoltaurineIBA 01/2022
1	AntigensIBA 01/2022
1	Butyrates (Butyrate)IBA 01/2022
1	Caseins (Casein)FDA Link 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	PropionatesIBA 01/2022
1	TunicamycinIBA 01/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2020
1	Drug CombinationsIBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2019
1	Abatacept (Orencia)FDA Link 11/2018
1	1,2,3,4-tetrahydroquinolineIBA 06/2018
1	Fluorescein-5-isothiocyanate (FITC)IBA 06/2018
1	Acridine OrangeIBA 06/2018
1	QuinazolinesIBA 06/2018
1	Propidium (Propidium Iodide)IBA 06/2018
1	Pattern Recognition ReceptorsIBA 01/2018
1	ChemokinesIBA 01/2018
1	Sorafenib (BAY 43-9006)FDA Link 10/2017
1	pyrazoleIBA 10/2017
1	7-azaindole dimerIBA 06/2017
1	CarbohydratesIBA 01/2017
1	Factor VIII (Coagulation Factor VIII)IBA 12/2016
1	canakinumab FDA Link 04/2016
1	Interleukin-1 (Interleukin 1)IBA 04/2016
1	Protein SIBA 11/2015
1	MetalsIBA 06/2015
1	Thromboplastin (Tissue Factor)IBA 04/2015
1	InterferonsIBA 04/2015
1	LipopolysaccharidesIBA 04/2015
1	Cell Surface ReceptorsIBA 04/2015
1	Blood Coagulation Factors (Coagulation Factor)IBA 04/2015
1	Glucose (Dextrose)FDA LinkGeneric 09/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2013
1	Cysteine (L-Cysteine)FDA Link 02/2013
1	InterleukinsIBA 10/2010
1	Peptide Hydrolases (Proteases)FDA Link 09/2010
1	Peptides (Polypeptides)IBA 09/2007
1	AntibodiesIBA 09/2007
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 09/2007
1	Y glycolipidIBA 01/2007
1	FucosyltransferasesIBA 01/2007
1	FucoseIBA 01/2007

Therapy/Procedure

3	Therapeutics 01/2021 - 09/2010
2	Immunotherapy 04/2016 - 12/2012
1	Thrombolytic Therapy 12/2020
1	Ligation 01/2018
1	Treatment Delay 02/2013